| Application no. and date | 14822371.2 (espacenet) (Federated) (European Patent Register), 20140709 | | Patent/reg. no. and date | DK/EP 3019240, 20240313 | | Publication date | 20160518 | | Priority no. and date | US 201361844369 P, 20130709, US 201361871813 P, 20130829 | | EP pub. no. and date |
EP 3019240 20160518 | | Effective date | | | Applicant/owner | Annexon, Inc., 1400 Sierra Point Parkway
Building C, 2nd Floor
Brisbane, CA 94005, US | | Applicant ref. no. | 169935/BT/GP | | Inventor | ROSENTHAL, Arnon, 150 Normandy Lane
Woodside, CA 94062, US,
LEVITEN, Michael, 502 Live Oak Lane
Emerald Hills, CA 94062, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 11/06 (2006.01) , C07K 16/18 (2006.01) | | Title | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf | | Int. application no. | US2014046042 | | Int. publication no. | WO2015006504 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
